Génération de Trésorerie (« Cash Flow ») avant financement de 15,0 millions d’euros, en progression comparé aux (132,2) millions d’euros de 2023, sous l'effet d'une gestion rigoureuse des stocks ...

Tevogen Bio will receive the remaining $8 million grant, totaling $10 million, from KRHP LLC this quarter, following a positive review of its progress, particularly in Tevogen.AI. Efficient operations ...

ORLANDO, Fla., March 03, 2025 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center ( Health-ISAC ), the non-profit industry-led organization that provides the global health sector with a ...

Today’s actions expand on Arbutus and Genevant’s ongoing enforcement proceeding in the U.S. District Court for the District of Delaware, seeking fair compensation for Moderna’s alleged infringement of ...

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any jurisdiction in which such offer, ...

The Phase 3 ARTEMIS trial (NCT06856577) is designed to evaluate the safety and efficacy of Ixo-vec in a randomized (1:1), double-masked, sham-controlled, two-arm study. The US-based trial is intended ...

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel ...

Cette équipe de l’Université McMaster (Ontario) vient d’identifier des métabolites sanguins qui paraissent influencer le ...

Consumers have noted that larger orders come with cost savings and free shipping, making bulk purchases a preferred option ...

Myeloma Action Month is an annual global awareness campaign that takes place every March to raise awareness and inspire action for multiple myeloma—a blood cancer that affects over 176,404 people ...

For each presentation, an archived replay will be accessible in the Investors section of the Keros website at https://ir.kerostx.com for up to 90 days following the conclusion of each event.

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease ...